Introduction of Sinopharm Holdings:
Sinopharm Holdings Limited was established in June 2003. It was listed in Hong Kong on September 23rd, 2009. As the largest distributor of drugs and healthcare products in China and a leading supply chain service provider, the company owns and operates the largest drug distribution network in China. Since 2005, it has ranked first in the annual sales and profits and taxes of pharmaceutical business in China for four consecutive years.
Sinopharm Holdings Guo Da Pharmacy Co., Ltd. is the largest drug retail operator in the drug retail industry in China. By the end of 20 1 1, the company had operated 1773 retail pharmacies with brands such as Guo Da, Concord, Dadesheng and Lerentang in 13 provinces, autonomous regions and municipalities directly under the Central Government, forming a nationwide drug retail chain network.
Coordinate the circulation of medicine and promote the process of internationalization. The company's seven pharmaceutical companies, including Sinopharm Yixin Pharmaceutical Co., Ltd., Shenzhen Zhijun Pharmaceutical Co., Ltd., Sinopharm Guo Rui Pharmaceutical Co., Ltd., Suzhou Zhijun Wanqing Pharmaceutical Co., Ltd., Sinopharm Xingsha Pharmaceutical (Xiamen) Co., Ltd., Sinopharm Shenzhen Chinese Medicine Co., Ltd. and Sinopharm Lerentang Hebei Pharmaceutical Co., Ltd., which mainly produce antibiotics, antineoplastic drugs, cardiovascular and cerebrovascular drugs, cough drugs and proprietary Chinese medicines, are constantly introducing world-class technologies to build a modern industrial platform with characteristics.